Abstract In this study, we examined the influence of cold and hot environments on methamphetamine (METH) neurotoxicity in both drug-naive rats and animals previously exposed to different types of nanoparticles (NPs). Since METH induces oxidative stress, we also examined how a potential chainbreaking antioxidant H-290/51 (Astra-Zeneca, Mölndal, Sweden) affects METH-induced neurotoxicity. Exposure of drug-naive rats to METH (9 mg/kg, s.c.) at 4, 21, or 34°C for 3 h resulted in breakdown of the blood-brain barrier (BBB), brain edema, and neuronal injuries, which all differed in severity depending upon ambient temperatures. The changes were moderate at 21°C, 120-180 % larger at 34°C, and almost absent at 4°C. In rats chronically treated with NPs (SiO2, Cu, or Ag; 50-60 nm, 50 mg/kg, i.p. for 7 days), METH-induced brain alterations showed a two-to fourfold increase at 21°C, a four-to sixfold increase at 34°C, and three-to fourfold increase at 4°C. SiO2 exposure showed the most pronounced METH-induced brain pathology at all temperatures followed by Ag and Cu NPs. Pretreatment with a potent antioxidant compound H-290/51 (50 mg/kg, p.o., 30 min before METH) significantly reduced brain pathology in naive animals exposed to METH at 21 and 34°C. In NPstreated animals, however, attenuation of METH-induced brain pathology occurred only after repeated exposure of H-290/51 (−30 min, 0 min, and +30 min). These observations are the first to show that NPs exacerbate METH-induced brain pathology in both cold and hot environments and demonstrate that timely intervention with antioxidant H-290/51 could have neuroprotective effects.
Introduction
Methamphetamine (METH) is increasingly abused by people living in both warm and cold environments and its use often results in not only behavioral or asocial activities, but also adverse health outcomes [1] [2] [3] [4] [5] [6] [7] [8] . Often, METH is consumed by people exposed to a wide variety of nanoparticles (NPs) from either environmental or industrial sources, thus making them more vulnerable to METH-induced alterations in brain functions and behaviors [9] [10] [11] [12] [13] . Thus, it is critical to examine how the neural effects of METH are modulated in different temperature environments, how they are changed under conditions of NPs exposure, and how they could be pharmacologically corrected to attenuate harmful effects of METH on brain and behavior [10] [11] [12] [13] [14] [15] [16] .
Previous experiments from our laboratory showed that engineered NPs from metals (e.g., Ag or Cu) enhanced brain trauma or METH neurotoxicity when given to rats at standard ambient temperatures [17] [18] [19] [20] . However, it is unclear how NPs exposure could affect METH neurotoxicity or behavioral disturbances at hot and cold environmental temperatures. Our previous work also suggests that METH (9 mg/kg, s.c.) administered to rats at standard ambient temperatures (21-22°C) induces profound leakage of the blood-brain barrier (BBB), brain edema and cell injuries; these effects are strongly potentiated at warm ambient temperatures (29°C) [21] [22] [23] . While these data indicate that heat stress potentiates METH neurotoxicity, data on the influence of cold stress are lacking. Therefore, it is of great interest and practical importance to investigate the influence and interaction between environmental temperature, METH-induced neurotoxicity, and chronic NPs exposure. As both METH and NPs induce oxidative stress [24] [25] [26] [27] , an antioxidant may mitigate METH-induced neural changes and attenuate the potentiation of METH-induced neurotoxicity by chronic NPs exposure.
In the present study, we examined different neural parameters related to neurotoxicity after METH administration at low (4°C), standard (21°C), and high (34°) environmental temperatures in both normal animals, and those previously chronically exposed to different types of NPs. We have chosen silica dust (SiO2), silver (Ag), and copper (Cu) NPs in the size range of 50-60 nm in order to see whether NP composition and particle size have specific effects on METH-induced neurotoxicity. In addition, we examined if and how a potent chain-breaking antioxidant compound (H-290/51, Astra-Zeneca, Mölndal, Sweden) might affect METH-induced neurotoxicity in both normal and NPs-exposed rats.
Materials and Methods

Animals
Experiments were carried out on male Sprague-Dawley rats (220-260 g body weight) housed in a controlled ambient temperature (21±1°C) with 12 h light and 12 h dark schedule. Rats were supplied with food and water ad libitum. All experiments were conducted according to the National Institute of Health (NIH) guidelines for care of experimental animals [28] and approved by Local Institutional Ethics Committees for animal experimentation.
Methamphetamine Administration (+)-Methamphetamine hydrochloride (Sigma-Aldrich, M8750) was freshly dissolved in saline before use and administered subcutaneously (s.c.) at the dose 9 mg/kg. The rats were allowed to survive 3 h after the METH administration [21] [22] [23] .
Exposure of Rats at Cold and Hot Ambient Temperatures
Some rats after METH or saline administration were placed in an environment-controlled chamber Comprehensive Lab Animal Monitoring System (CLAMS, Columbus Instruments, Columbus, OH, USA) at either 4 or 34°C for 3 h. Other groups of rats after METH/saline administration remained housed at a room temperature (21°C). There were no differences in BBB permeability or brain pathology between METH-exposed rats kept either at room temperature (21°C) or placed in environment-controlled chambers at 21°C (Sharma HS, unpublished observations). Thus, all the following experiments were conducted at room temperature (21°C).
Administration of Nanoparticles
Engineered nanoparticles (NPs), e.g., copper (Cu), silver (Ag), and silica dust (SiO2) were commercially procured from Denzlingen, Germany, and cover a range between 50 and 60 nm. The size of nanoparticles was checked using transmission electron microscopy as described earlier [29, 30] . The nanoparticles were suspended in 0.05 % Tween 80 in 0.7 % NaCl solutions. In a separate group of rats, Ag, Cu, or SiO2 NPs were administered at the dose 50 mg/kg, i.p. once daily for 1 week. On the 8th, day these animals were subjected to METH administration (9 mg/kg, s.c.) at 4, 21, and 34°C.
Measured Parameters
Blood-Brain Barrier Permeability
The BBB breakdown was measured using Evans blue and radioiodine (
[131]-Iodine) tracers that bind to serum proteins, largely albumin, when introduced into circulation [20] [21] [22] . Thus, leakage of these tracers across the BBB represents extravasation of serum-protein complexes. Evans blue dye (2 %, 0.3 ml/100 g) and radioiodine (106 CPM or 10 μCi/100 g) were administered into the right femoral vein 3 h after METH administration under Equithesin anesthesia (0. 3 ml/100 g, i.p.). After 5 to 8 min circulation of Evans blue and radioiodine tracers, the animals were perfused with 0.9 % saline to washout the remaining blood from the blood vessels. Immediately before saline perfusion, about 1 ml of whole blood was withdrawn via cardiac puncture for later determination of whole blood radioactivity [29] . After saline perfusion, the brain was dissected out and the extent of Evans blue dye spread in brain tissue was examined using a magnifying lens. The desired structures of the brain were then dissected out, weighed, and radioactivity was measured in a 3-in Gamma Counter (Packard, USA). After measuring the radioactivity in the brain, samples were dissolved in a mixture of sodium sulfate and acetone to extract the Evans blue due that had entered into the brain. The samples were analyzed in spectrophotometer for colorimetric determination of Evans blue against the standard solution for the dye at 620 nm [20] [21] [22] .
Brain Edema Formation
The brain edema formation was evaluated by measuring brain water content [20, 21] . Immediately after the brains were taken out, the desired areas of the brains were dissected out, weighed, and placed in an oven at 90°C for 72 h in order to evaporate the water content of the tissue. Dry weights of the samples were then recorded. The brain water content was calculated from the differences between the wet and dry weights of the samples. Volume swelling (% ƒ) of the brain was calculated from the differences in brain water between the controls and experimental groups using the formula of Elliott and Jasper (1949) [31] . Approximately 1 % increase in water corresponds to 4 % increase in volume swelling [see 21].
Morphological Investigations
Neuronal Injury
Neuronal injuries were examined using histopathological techniques on paraffin sections. After initial saline perfusion, animals were perfused with 4 % buffered paraformaldehyde (ca. 250 ml) at 90 Torr perfusion pressure using a peristaltic pump (Harvard Apparatus, USA). Animals were then wrapped in an aluminum foil and placed at 4°C in a refrigerator overnight. On the 2nd day, the brains were dissected out and placed in the same fixative at 4°C for 1 week. Then, 3-to 5-μm coronal sections passing through hippocampus were cut and embedded in paraffin using an automated tissue processor. About 3-μm thick paraffin sections were cut and stained with either Nissl or hematoxylin & eosin (H&E) for analyzing neuronal damages [20] [21] [22] . The images were examined in an Inverted Carl Zeiss Microscope and recoded on a digital camera (Olympus f 1.4). The images from control and experimental groups were analyzed using commercial Photoshop software (12.4.0) using identical filters [32] .
Astrocytic Reaction
Activation of astrocytes was examined by analyzing glial fibrillary acidic protein (GFAP) immunoreactivity using the standard commercial protocol [20] [21] [22] . In brief, 3-μm paraffin sections were deparaffinized, and endogenous peroxidase was inhibited with 0.3 % hydrogen peroxide with 1 % nonimmune horse serum in phosphate-buffered saline (PBS, pH 7.4) for 20 min. Then, the sections were incubated for 8 h with monoclonal anti-GFAP serum (DAKO, Hamburg, Germany) diluted 1:500 in PBS at 4°C. After incubation with biotinylated horse anti-mouse immunoglobulin IgG at a 1:50 dilution and avidin-biotin complex (ABC) (Vector Laboratories, Burlingame, USA) for 45 min, the brown reaction product was developed with 3,3′-tetraaminobenzidine and hydrogen peroxide in 0.05 M Tris-HCl buffer (pH 7.4) for 4 min [33, 34] . The paraffin sections of the control and METH-treated groups were processed in parallel. A few sections were counterstained with hematoxylin-eosin for good contrast [34, 35] . The GFAP immunoreactivity in selected brain areas was assessed in a blind fashion by two independent observers.
Treatment with H-290/51
The chain-breaking antioxidant, H-290/5, a synthetic antioxidative agent (cis-7-methyl-9-methoxy-5,5 a,6,10 btetrahydroindeno [2,1-b] indole; Astra-Zeneca, Mölndal, Sweden) was given to rats orally at the dose of 50 mg/kg as described earlier [36] . The H-290/51 suspension was prepared in sterile water (5 mg/ml) and administered in rats by oral gavage [17, 20, 31, 41] . In experiments with the combined use of METH and NPs, this drug was administered repeatedly in order to achieve high concentrations in the plasma. Thus, in these groups H-290/51 treatment was given at three time points: −30, 0, and 30 min with respect to METH administration [36, 41] .
Physiological Parameters
Skin and Core Body Temperatures
The skin and core body temperatures were measured using thermistor probes (Yellow Springfield, USA) attached to a 12-channel telethermometer (Aplab Electronics, UK). Skin temperature (Ts) was recorded from the surface of the tail and the core body temperature (Tc) was recorded from the rectum (~4 cm insertion) [37] .
Cardiovascular Parameters
The mean arterial blood pressure (MABP) was recorded at the end of the experiment from an indwelling cannula into the left carotid artery placed aseptically and retrogradely towards the heart 7 days prior drug treatments. At the time of recording, the carotid artery catheter was connected to a Strain Gauge Pressure Transducer (Statham P23, USA) and connected to a chart recorder (Electromed, UK). At the time of MABP recording, both heart and respiration rates were also recorded using specific electrodes that were placed appropriately and connected with the chart recorder [37] [38] [39] .
Arterial pH and Blood Gases
Immediately before MABP recording,~1 ml sample of arterial blood was withdrawn from the carotid artery catheter for measurement of arterial pH and blood gases in a Radiometer Apparatus (Copenhagen, Denmark) [37] .
Statistical Analyses
ANOVA followed by Dunnett's test for multiple group comparison from one control was used to determine statistical significance of the data obtained. The statistical analyses were performed using Stat View 5 commercial software (Abacus Concepts Inc. CA, USA) on a Macintosh Computer in a Classic Environment (System 9.8.6). A p value less than 0.05 was considered significant.
Results
Methamphetamine Induces Blood-Brain Barrier Breakdown METH administered to rats at standard room temperature (21°C) induced BBB disruption in several brain areas as is evident from Evans blue staining. Different areas of cerebral cortex (e.g., cingulate, frontal, occipital, and temporal cortices,) showed mild to moderate blue staining. The ventricular walls of the lateral ventricles were also stained. Mild blue staining was also seen in the hippocampus and caudate nucleus. Measurements of radioiodine extravasation and Evans blue leakage also showed significant increases compared to the drug-free control (Table 1) . When METH was administered at hot ambient temperatures (34°C), the intensity of the BBB breakdown was strongly increased, as evidenced by deeper Evans blue staining in these brain areas and significant increases in Evans blue levels. In this case, the piriform cortex, infundibulum, thalamus, and hypothalamus also showed intense blue staining. Radioiodine extravasation was also enhanced significantly when METH was used at 34°C. However, METH administered at low ambient temperatures (4°C) induced only a very slight, not significant increase in Evans blue levels and
Iodine. Although METH induced BBB leakage in all tested structures, the extent of radioiodine extravasation and its changes induced by METH was strongly influenced by different ambient temperatures (Table 2) .
Methamphetamine Induces Brain Edema
METH administered at room temperature induced profound brain edema and volume swelling (Table 1) . Both the brain water content and volume swelling significantly increased when the drug was used at 34°C, but both these parameters did not change with METH treatment at 4°C.
Methamphetamine Induces Astrocytic Activation and Neuronal Damage
METH treatment at 21°C resulted in the activation of astrocytes located in areas of neuronal damage in the cerebral cortex, hippocampus, and cerebellum (Table 1) . Few GFAPpositive astrocytes were located in the perivascular areas in these brain regions. After METH exposure at 34°C, the number of GFAP-positive astrocytes significantly increased and were found in other brain areas, including the thalamus, hypothalamus, caudate nucleus, and colliculi beside the cerebral cortex, hippocampus, and cerebellum (Fig. 1a) . Similar to other parameters, only a few astrocytes showed GFAP immunoreactivity in the cortex following METH injection at 4°C, and the difference vs. control was not significant.
METH administration at room temperature induced profound neuronal damages in several areas of the brain, including the cerebral cortex, hippocampus, and cerebellum. The distorted neurons were largely located in the edematous areas of the brain that showed sponginess of the neuropil (Table 1 and Fig. 1a ). These neuronal abnormalities were exacerbated in rats treated with METH at 34°C. The damaged neurons in this group increased in number, and the damage was extended to other brain areas, including the thalamus, hypothalamus, caudate nucleus, and colliculi. Interestingly, rats treated with METH at 4°C showed only minimal neuronal injuries limited to the cerebral cortex, and the number of abnormal cells did not differ from 4°C control.
Nanoparticles Exacerbate Methamphetamine-Induced Brain Pathology
Compared to the NPs-free controls, METH administered to NPs-exposed rats at room temperature induced much more robust changes in BBB permeability and glial activation, stronger brain edema, and more profound neuronal injuries (Table 1 ). Similar to intact rats, the changes in all parameters were lower when METH was administered at 4°C and higher at 34°C (see Fig. 1b ). In contrast to intact animals, however, NPs-treated rats showed profound neuronal damage, BBB breakdown, and edema formation after METH treatment in cold environment; the difference vs. 4°C control was significant for each parameter in each of the three NP groups. Interestingly, the rats exposed to SiO2 NPs exhibited higher brain damage and stronger glial activation after METH administration at all ambient temperatures. Ag NPs induced a moderate amount of brain damage and glial activation, with the Cu NPs showing the least effect. NPs exacerbated METHinduced neural responses in all tested structures, but the changes showed certain structural variability (Table 2) .
Antioxidant Compound H-290/51 Induces Neuroprotection
Pretreatment of rats with the chain-breaking antioxidant H-290/51 (50 mg/kg) 30 min before METH administration significantly reduced METH-induced BBB breakdown, brain edema formation, and brain cell pathology in rats exposed to this drug at either 21 or 34°C (Table 3) . However, NPsexposed rats must be treated with H-290/51 three times once 30 min before, immediately after, and 30 min following METH administration in order to observe a reliable neuroprotective effect (see also Fig. 1c ).
Physiological Variables in METH-treated Groups
METH treatment at room temperature induced profound hyperthermia as seen by increases in rectal (Tc) and skin (Ts) temperatures measured at 3 h post-injection (Table 4 ). The increases in Tc or Ts were enhanced when rats were exposed to METH at Values are mean±SEM obtained from five to eight rats at each point. Volume swelling (% ƒ) was calculated according to Elliott and Jasper [31] and adjusted to the nearest round figure for simplicity; nil absent *p<0.05; **p<0.01; and ***p<0.001 significant differences within groups, i.e., 4 vs. 21°C and 34 vs. 21°C o p<0.05; oo p<0.01; and ooo p<0.001 significant differences vs. control, i.e., between effects of METH at the same temperature in NPs-exposed and intact rats 34°C. However, rats treated with METH at 4°C showed significant hypothermia; both Tc and Ts were much lower compared to the control group. In NPs-exposed rats METH-induced temperature increases were larger when the drug was administered at room and hot ambient temperatures. The decline in Tc and Ts seen at 4°C was considerably mitigated.
Rats treated with METH at room temperature showed slight increases in MABP and PaO 2 , a mild decline in PaCO 2 , and no changes in arterial pH. In a hot environment, METH resulted in a slightly larger rise in MABP (non significant change), whereas arterialpHand blood gases did notdiffer significantly from METH-treated rats at room temperature.
METH administration in cold temperature resulted in a slight hypotension, but again, the arterial pH and blood gases were not much affected. The heart and respiration rates were increased by METH use at room temperature. These increases were larger in a hot environment but much smaller in a cold environment.
Interestingly, NPs-exposed rats showed higher MABP, heart rate, and respiration rates at all temperatures (Table 4) . However, the arterial pH did not change. A slight increase in PaO 2 and a significant decrease in PaCO 2 were observed in the METH-treated group after NPs intoxication, but this change was not affected further by either cold or hot exposure. H-290/51 treatment did not significantly alter these physiological variables either in normal or NPs-exposed rats that received METH at any ambient temperatures (Table 4) .
Discussion
METH is a drug of abuse with neurotoxic properties. Previous reports from our laboratory showed that METH resulted in the breakdown of the BBB and brain injury in both rats and mice [21] [22] [23] [40] [41] [42] . Our studies also showed that METH administered at warm ambient temperatures (29°C) induced larger temperature increases and more severe neuronal injury [21] [22] [23] 43] . The present study confirms our previous work indicating that METHinduced neurotoxicity is temperature-dependent and further elucidates how ambient temperature influences METH-induced neuronal responses. As such, METH administered at 34°C showed massive brain pathology as The primary novel finding of this study is that rats chronically exposed to NPs show much stronger METH-induced neural responses than intact animals at each ambient Values are mean±SEM obtained from five to eight rats at each point Tc core body temperature, Ts skin (tail) temperature, MABP mean arterial blood pressure *p<0.05 significant differences within groups, i.e., 4 vs. 21°C and 34 vs. 21°C o p<0.05 significant differences between particle-exposed and particle-free, intact rats a H-290/51 single dose b H-290/51 repeated doses temperature. Interestingly, in NPs-exposed rats, METH induced profound neurotoxicity at a low temperature-a feature absent in intact rats. Thus, NPs aggravate METH-induced neurotoxicity within the wide range of environmental temperatures. The mechanisms by which NPs could exacerbate METH toxicity in both cold and hot environments are not well known. However, there are reasons to believe that hypothermia induced by METH at cold ambient temperatures is not neuroprotective. This is apparent from our finding that pentobarbital-anesthetized rats that have low brain and body temperatures showed considerable leakage of BBB to albumin and neuronal injuries [44] . Forced swim experiments, in which rats were allowed to swim at 30°C for 30 min, provide further evidence of BBB leakage despite lowered body temperature (~5°C decrease) [45, 46] . Moreover, drugs that blocked the BBB leakage in this model did not prevent hypothermia induced by the forced swim test [45, 46] . As such, hypothermia per se does not protect the brain from BBB damage caused by either forced swim or METH administration. The reduction or minimal damage done by METH at 4°C in rats may be due to an attenuation of drug-induced cellular and/ or oxidative stress.
The dual role of temperature is further supported by our findings in NPs-exposed rats that received METH at 4°C. These rats did not show hyperthermia as their body temperature remained slightly below than the average in the control group. However, they exhibited massive BBB breakdown and brain pathology. Since NPs induce profound oxidative and cellular stress, it appears that a combination of METH and NPs could induce BBB breakdown even in a cold environment. Since NPs alone at 4°C did not induce BBB breakdown or neuronal injury, it is likely that a combination of METH and NPs are needed to induce brain pathology in a cold environment.
This observation indicates that METH users that live in polluted environments may develop stronger mental abnormalities or brain dysfunctions than METH users living in cleaner environment. Obviously, people that are exposed to silica dust and other NPs from industrial sources or gunpowder explosions could be more vulnerable to substance abuse and drug-induced deterioration of brain functions. However, further studies are needed to prove these points.
As compared to Ag or Cu NPs exposure, we observed that SiO2 NPs exposure resulted in more profound BBB breakdown, stronger brain edema formation and larger neuronal or glial injuries following METH administration regardless of ambient temperature. This suggests that the inherent properties of NPs might play a key role in brain dysfunctions induced by METH, although the exact mechanisms of such an interaction are unknown [47] [48] [49] . However, available evidence suggests that the zeta potential, electric charges and dispersion of NPs in biological or surrounding medium could determine the actual effects of NPs in any environment [50] . Previous studies also suggest that SiO2 NPs induce more robust neuronal reactions and more severe disruptions in BBB permeability during heat exposure and spinal cord injury than either Ag or Cu NPs [18, 51, 52] . Therefore, the present results further support the idea that SiO2 NPs enhance METHinduced neurotoxicity more strongly than other metal NPs (i.e., Ag and Cu).
The most likely cause for NPs-induced exacerbation of neurotoxic effects of METH is an enhanced oxidative stress in the CNS. This idea is supported by the fact that exposure to Cu, Ag, or Al NPs during 4-h whole body hyperthermia results in four to sixfold increases in oxidative stress compared to saline-treated heat-exposed animals [53, Sharma HS unpublished observations]. Thus, it would be interesting to measure oxidative stress in animals exposed to METH with or without NPs at different ambient temperatures.
The role of oxidative stress in METH-induced neurotoxicity together with NPs intoxications is further supported by our observations with H-290/51. The H-290/ 51 is a potent, chain-breaking antioxidant that is capable of attenuating spinal cord injury, neuronal damages, and edema formation in SiO 2 -treated rats [20, 51] . Based on these observations, in this study, we pretreated animals with H-290/51, and then administered METH at 21 and 34°C. Since H-290/51 was able to attenuate METH neurotoxicity in these animals, we believe that oxidative stress plays an important role in METH-induced neurotoxicity. However, when METH was used in NPsexposed rats, repeated treatment with H-290/51 or higher doses of the drug was necessary to reduce METH neurotoxicity at cold, neutral, and hot ambient temperatures. As mentioned earlier [17, 20, 32, 41, 56] , the drug is a synthetic antioxidant that works as a chain-breaking antioxidant. This was tested in vivo and 50 mg/kg dose was found to be optimal [17] . In situations of NPs exposure that in itself induces oxidative stress, additional two doses of H-290/51 were needed. In this group, one or two doses were ineffective (Sharma HS unpublished observation). This confirms the idea that NPs intoxication induces additional oxidative stress that requires a higher dose of the antioxidant to induce neuroprotection. Nanotechnology techniques could be used to more efficiently deliver this drug into brain tissue, and thus enhance its bioavailability and therapeutic effect. We have shown earlier that TiO 2 -nanowired delivery of drugs during CNS trauma has a superior neuroprotective effect than the traditional drug delivery [54] [55] [56] [57] [58] . It could be of interest to examine whether nanowire drug delivery of H-290/51 could be more effective in attenuating METH-induced neurotoxicity at different ambient temperatures. This work is currently in progress in our laboratory.
In conclusion, our results are the first to show that NPs intoxication exacerbates METH-induced neurotoxicity that occurs in both cold and hot environments. This METHinduced neurotoxicity could be possibly prevented by the timely administration of antioxidant compound H-290/51. This novel finding indicates that oxidative stress plays an important role in METH-induced neurotoxicity and is exacerbated by NPs intoxication.
